-
2721
Prevalence and Determinants of Diarrheal Diseases among Under-Five Children in Horo Guduru Wollega Zone, Oromia Region, Western Ethiopia: A Community-Based Cross-Sectional Study
Published 2021-01-01“…Therefore, educating mothers/caregivers on diarrheal disease prevention methods, child spacing, regular hand washing practice after disposing child feces, safely disposing liquid waste, and vaccinating all eligible children against measles should be a priority area of intervention for diarrheal disease prevention. …”
Get full text
Article -
2722
Dynamic Roles of RNA and RNA Epigenetics in HTLV-1 Biology
Published 2025-01-01“…This review will highlight the dynamic roles of known RNA and post-transcriptional RNA epigenetic modifications within HTLV-1 biology, including viral <i>hbz</i>, long noncoding RNAs, microRNAs (miRNAs), transfer RNAs (tRNAs), R-loops, N6-methyladenosine (m<sup>6</sup>A) modifications, and RNA-based therapeutics and vaccines.…”
Get full text
Article -
2723
Focused Review: Insight and Updates on COVID-19 from Progress in Microbes and Molecular Biology
Published 2023-06-01“…This focused review provides an overview of the published COVID-19 cases, including the first case detected in respective countries, preventive measures implemented, and vaccinations available for some countries, depending on the time it was written. …”
Get full text
Article -
2724
-
2725
Helicobacter pylori: Beginning the Second Decade
Published 1995-01-01“…The Houston meeting was followed by the Tenth World Congresses of Gastroenterology from October 2 to 7, 1994 in Los Angeles, California, again with scores of presentations and posters on topics ranging from the epidemiology of H pylori infection to steps towards the development of a human vaccine. All this was in addition to important new work presented earlier in 1994 in New Orleans during Digestive Diseases Week. …”
Get full text
Article -
2726
Design and Performance of Solar PV Integrated Domestic Vapor Absorption Refrigeration System
Published 2021-01-01“…They can also help lifesaving vaccines to reach even the isolated parts of the world. …”
Get full text
Article -
2727
Chandipura virus: The 2024 resurgence and Gujarat outbreak
Published 2024-12-01“…Public health initiatives concentrate on vector management and supportive care because there is no particular antiviral medication or vaccine available. Recently, Gujrat has witnessed the biggest outbreak of Chandipura virus in 2024 and it may become a big health concern. …”
Get full text
Article -
2728
De novo design of protein minibinder agonists of TLR3
Published 2025-01-01“…Several nucleic acid-based TLR3 agonists have been explored clinically as vaccine adjuvants in cancer and infectious disease, but present substantial manufacturing and formulation challenges. …”
Get full text
Article -
2729
Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy
Published 2025-01-01“…Immunotherapy, including immune checkpoint inhibitors, tumor vaccine therapy, oncolytic virotherapy, and adoptive cell therapy, has made remarkably breakthroughs in the field of oncology. …”
Get full text
Article -
2730
Different Transcriptional Profiles of Human Monocyte-Derived Dendritic Cells Infected with Distinct Strains of Mycobacterium tuberculosis and Mycobacterium bovis Bacillus Calmette-...
Published 2011-01-01“…In order to analyze dendritic cells (DCs) activation following infection with different mycobacterial strains, we studied the expression profiles of 165 genes of human monocyte-derived DCs infected with H37Rv, a virulent Mycobacterium tuberculosis (MTB) laboratory strain, CMT97, a clinical MTB isolate, Mycobacterium bovis bacillus Calmette-Guérin (BCG), Aventis Pasteur, and BCG Japan, both employed as vaccine against tuberculosis. The analysis of the gene expression reveals that, despite a set of genes similarly modulated, DCs response resulted strain dependent. …”
Get full text
Article -
2731
The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet—Remaining Challenges in Hepatitis C
Published 2016-01-01“…Comprehensive prevention strategies, including enhanced harm reduction, broader screening, widespread treatment, and vaccine development, are far from being realized. …”
Get full text
Article -
2732
Expression of Proinflammatory and Regulatory Cytokines via NF-κB and MAPK-Dependent and IFN Regulatory Factor-3-Independent Mechanisms in Human Primary Monocytes Infected by Mycob...
Published 2011-01-01“…Thus, by inducing a specific cytokine profile, Mtb can influence the immunoregulatory properties of monocytes, which represent important target of novel vaccinal strategies against Mtb infection.…”
Get full text
Article -
2733
Quinoline and Quinazoline Alkaloids against COVID-19: An In Silico Multitarget Approach
Published 2021-01-01“…Although, recently, vaccines have been approved for the prevention of COVID-19, there is still an urgent need for the discovery of more efficacious and safer drugs especially from natural sources. …”
Get full text
Article -
2734
An HPLC-based Assay to Study the Activity of Cyclic Diadenosine Monophosphate (C-di-AMP) Synthase DisA from Mycobacterium smegmatis
Published 2024-12-01“…Additionally, c-di-AMP demonstrates potent adjuvant properties, particularly when administered alongside the Bacillus Calmette–Guérin (BCG) vaccine through mucosal routes. Because of its pivotal role in bacterial signaling and host immune response, this molecule has garnered significant interest from the pharmaceutical industry. …”
Get full text
Article -
2735
Passive Protection of Diabetic Rats with Antisera Specific for the Polysaccharide Portion of the Lipopolysaccharide Isolated from Pseudomonas pseudomallei
Published 1994-01-01“…The wide distribution of the polysaccharide antigen among isolates of P pseudomallei used in this study and the protective role of antibody to the conjugated polysaccharide antigen suggest potential as a vaccine.…”
Get full text
Article -
2736
Optimal control of chikungunya disease: Larvae reduction, treatment and prevention
Published 2012-02-01“…Three main efforts are considered in order to limit the virus transmission. Indeed, there is no vaccine nor specific treatment against chikungunya, that is why the main measures to limit the impact of such epidemic have to be considered. …”
Get full text
Article -
2737
Lipid Antigens: Revealing the Hidden Players in Adaptive Immune Responses
Published 2025-01-01“…These advancements have paved the way for lipid-based vaccines and immunotherapies through the application of nanoparticles and synthetic lipid antigens designed to boost immune responses against cancers and infectious diseases. …”
Get full text
Article -
2738
Fundamentals and Methods for T- and B-Cell Epitope Prediction
Published 2017-01-01“…There is great interest in identifying epitopes in antigens for a number of practical reasons, including understanding disease etiology, immune monitoring, developing diagnosis assays, and designing epitope-based vaccines. Epitope identification is costly and time-consuming as it requires experimental screening of large arrays of potential epitope candidates. …”
Get full text
Article -
2739
The Prospects for the Therapeutic Implications of Genetically Engineered Probiotics
Published 2020-01-01“…The lactic acid bacilli are predominantly opposite as they already have gained attention owing to their health-promoting benefits and their safety for human consumption; therefore, their use, especially as a delivery agent of vaccines and drugs, is gaining attention. The tailoring of probiotic strains will not only improve the data regarding the probiotic potential of these strains but also clinch the doubts concerning these probiotics. …”
Get full text
Article -
2740
Virulence and pathogenicity of group B Streptococcus: Virulence factors and their roles in perinatal infection
Published 2025-12-01“…We conclude by addressing current efforts in vaccine development, underscoring the need for effective prevention strategies against this pervasive pathogen.…”
Get full text
Article